Federal district court cases that are filed pursuant to the Hatch-Waxman Act
This chart summarizes the case name, presiding judge, drug, and patents-at-issue in all federal district court cases that are filed pursuant to the Hatch-Waxman Act. It also includes the same information for proceedings before the Patent Trial and Appeal Board concerning Orange Book-listed patents.
| Case Name | Date Filed | Judge | Drug | Patent No(s). |
| Novo Nordisk Inc. v. Mylan Pharms. Inc., 24-0775 (D. Del.) | Jul 1, 2024 | Hon. Colm F. Connolly | Ozempic® (semaglutide subcutaneous solution) | 8,129,343 10,335,462 |
| Currax Pharms. LLC v. Taro Pharm. Indus. Ltd., 24-7446 (D.N.J.) | 1-Jul-24 | Jul | Silenor® (doxepin HCl tablets) | 7,915,307 8,513,299 9,107,898 9,486,437 9,572,814 9,861,607 10,238,620 10,653,660 10,653,662 11,110,074 |
| Bristol-Myers Squibb Co. v. Synthon BV, 24-0780 (D. Del.) | 2-Jul-24 | Hon. Gregory B. Williams | Zeposia® (ozanimod capsules) | 11,680,050 |
| Axsome Malta Ltd. v. Aurobindo Pharma USA, Inc., 24-7511 (D.N.J.) | 2-Jul-24 | Hon. Madeline Cox Arleo | Sunosi® (solriamfetol tablets) | 11,969,404 |
| Currax Pharms. LLC v. Taro Pharm. Indus. Ltd., 24-5040 (S.D.N.Y.) | 2-Jul-24 | Hon. Cathy Seibel | Silenor® (doxepin HCl tablets) | 7,915,307 8,513,299 9,107,898 9,486,437 9,572,814 9,861,607 10,238,620 10,653,660 10,653,662 11,110,074 |
| Novo Nordisk Inc. v. Mylan Pharms. Inc., 24-0067 (N.D.W.V.) | 2-Jul-24 | Hon. Thomas S. Kleeh | Ozempic® (semaglutide subcutaneous solution) | 8,129,343 10,335,462 |
| Veloxis Pharms., Inc. v. Alkem Labs. Ltd., 24-0784 (D. Del.) | 3-Jul-24 | Hon. Jennifer L. Hall | Envarsus XR® (tacrolimus extended-release tablets) | 8,685,998 9,549,918 10,166,190 10,864,199 11,110,081 11,123,331 11,419,823 |
| Salix Pharms., Inc. v. Carnegie Pharms., LLC, 24-7531 (D.N.J.) | 3-Jul-24 | Hon. Susan D. Wigenton | Colazal® (balsalazide disodium capsules) | 7,452,872 7,625,884 |
| Jazz Pharms. Research UK Ltd. v. Apotex Inc., 24-7550 (D.N.J.) | 3-Jul-24 | Hon. Michael E. Farbiarz | Epidiolex® (cannabidiol oral solution) | 11,963,937 |
| Otsuka Pharm. Co., Ltd. v. Sun Pharm. Indus. Ltd., 24-0789 (D. Del.) | 5-Jul-24 | Hon. Jennifer L. Hall | Abilify Maintena® (aripiprazole extended-release injectable suspension) | 10,525,057 10,980,803 1,154,553 11,344,547 11,400,087 11,648,347 |
| Radius Health, Inc. v. Orbicular Pharm. Technologies Private Ltd., 24-11770 (D. Mass.) | 10-Jul-24 | Hon. Richard G. Stearns | Tymlos® (abaloparatide injection) | 11,977,067 |
| Pacira Pharms., Inc. v. eVenus Pharms. Labs. Inc., 24-7680 (D.N.J.) | 10-Jul-24 | Hon. Madeline Cox Arleo | Exparel® (bupivacaine liposome injectable suspension) | 11,925,706 |
| Pierre Fabre Medicament SAS v. Rubicon Research Private Ltd., 24-0811 (D. Del.) | 12-Jul-24 | Hon. Jennifer L. Hall | Hemangeol® (propranolol HCl oral solution) | 8,338,489 8,987,262 |
| Vanda Pharms. Inc. v. MSN Pharms. Inc., 24-0815 (D. Del.) | 12-Jul-24 | Hon. Jennifer L. Hall | Hetlioz LQ® (tasimelteon oral suspension) | 10,179,119 11,266,622 11,285,129 11,850,229 10,610,510 10,980,770 11,759,446 |
| Bristol-Myers Squibb Co. v. Apotex, Inc., 24-0818 (D. Del.) | 15-Jul-24 | Hon. Gregory B. Williams | Zeposia® (ozanimod capsules) | 11,680,050 |
| American Regent, Inc. v. Gland Pharma Ltd., 24-7756 (D.N.J.) | 15-Jul-24 | Hon. Brian R. Martinotti | Tralement® (trace zinc, copper, manganese, selenium injection) Multrys® (trace zinc, copper, manganese, selenium injection) | 11,786,548 11,975,022 11,998,565 |
| American Regent, Inc. v. Fresenius Kabi USA, LLC, 24-0824 (D. Del.) | 16-Jul-24 | Hon. Maryellen Noreika | Selenious Acid | 11,998,565 |
| American Regent, Inc. v. Long Grove Pharms., LLC, 24-0825 (D. Del.) | 16-Jul-24 | Hon. Maryellen Noreika | Selenious Acid | 11,998,565 |
| American Regent, Inc. v. Accord Healthcare Inc., 24-7791 (D.N.J.) | 16-Jul-24 | Hon. Brian R. Martinotti | Selenious Acid | 11,998,565 |
| American Regent, Inc. v. Aspiro Pharma Ltd., 24-7794 (D.N.J.) | 16-Jul-24 | Hon. Brian R. Martinotti | Selenious Acid | 11,998,565 |
| American Regent, Inc. v. Cipla USA, Inc., 24-7796 (D.N.J.) | 16-Jul-24 | Hon. Brian R. Martinotti | Selenious Acid | 11,998,565 |
| American Regent, Inc. v. Dr. Reddy’s Labs., Inc., 24-7799 (D.N.J.) | 16-Jul-24 | Hon. Brian R. Martinotti | Selenious Acid | 11,998,565 |
| American Regent, Inc. v. Fresenius Kabi USA, LLC, 24-7801 (D.N.J.) | 16-Jul-24 | Hon. Brian R. Martinotti | Selenious Acid | 11,998,565 |
| American Regent, Inc. v. Gland Pharma Ltd., 24-7802 (D.N.J.) | 16-Jul-24 | Hon. Brian R. Martinotti | Selenious Acid | 11,998,565 |
| American Regent, Inc. v. Hikma Pharms. USA Inc., 24-7803 (D.N.J.) | 16-Jul-24 | Hon. Brian R. Martinotti | Selenious Acid | 11,998,565 |
| American Regent, Inc. v. Long Grove Pharms., LLC, 24-7804 (D.N.J.) | 16-Jul-24 | Hon. Brian R. Martinotti | Selenious Acid | 11,998,565 |
| American Regent, Inc. v. RK Pharma, Inc., 24-7805 (D.N.J.) | 16-Jul-24 | Hon. Brian R. Martinotti | Selenious Acid | 11,998,565 |
| American Regent, Inc. v. Somerset Therapeutics, LLC, 24-7807 (D.N.J.) | 16-Jul-24 | Hon. Brian R. Martinotti | Selenious Acid | 11,998,565 |
| American Regent, Inc. v. Steriscience Pte. Ltd., 24-7809 (D.N.J.) | 16-Jul-24 | Hon. Brian R. Martinotti | Selenious Acid | 11,998,565 |
| American Regent, Inc. v. Sun Pharm. Indus. Ltd., 24-7810 (D.N.J.) | 16-Jul-24 | Hon. Brian R. Martinotti | Selenious Acid | 11,998,565 |
| American Regent, Inc. v. Xiromed, LLC, 24-7811 (D.N.J.) | 16-Jul-24 | Hon. Brian R. Martinotti | Selenious Acid | 11,998,565 |
| American Regent, Inc. v. Zydus Pharms. (USA) Inc., 24-7812 (D.N.J.) | 16-Jul-24 | Hon. Brian R. Martinotti | Selenious Acid | 11,998,565 |
| Impax Labs., LLC v. Dr. Reddy’s Labs., Ltd., 24-7875 (D.N.J.) | 18-Jul-24 | Hon. Stanley R. Chesler | Rytary® (carbidopa / levodopa extended-release capsules) | 8,557,283 9,089,608 9,463,246 9,533,046 9,901,640 |
| Allergan Pharms. Int’l Ltd. v. Macleods Pharms. Ltd., 24-0847 (D. Del.) | 19-Jul-24 | Hon. Maryellen Noreika | Savella® (milnacipran HCl tablets) | 7,994,220 |
| Ferring Pharms. Inc. v. Jiangsu Hansoh Pharm. Group Co., Ltd., 24-7904 (D.N.J.) | 19-Jul-24 | Hon. Evelyn Padin | Firmagon® (degarelix for injection) | 8,841,081 9,877,999 11,766,468 11,826,397 |
| TherapeuticsMD, Inc. v. Sun Pharm. Indus. Ltd., 24-7974 (D.N.J.) | 24-Jul-24 | Hon. Brian R. Martinotti | Imvexxy® (estradiol vaginal inserts) | 9,180,091 9,289,382 10,258,630 10,398,708 10,471,072 10,537,581 10,568,891 10,668,082 10,806,697 10,835,487 10,888,516 11,065,197 11,116,717 11,123,283 11,241,445 11,246,875 11,266,661 11,304,959 11,351,182 11,497,709 |
| Teva Branded Pharm. Products R&D, Inc. v. Armstrong Pharms., Inc., 24-0869 (D. Del.) | 25-Jul-24 | Hon. Maryellen Noreika | ProAir® HFA (albuterol sulfate inhalation aerosol) | 9,463,289 |
| AstraZeneca Pharms. LP v. Natco Pharma Ltd., 24-8162 (D.N.J.) | 31-Jul-24 | Hon. Robert Kirsch | Lynparza® (olaparib tablets) | 12,048,695 |
| AstraZeneca Pharms. LP v. Sandoz Inc., 24-8164 (D.N.J.) | 31-Jul-24 | Hon. Robert Kirsch | Lynparza® (olaparib tablets) | 12,048,695 |
| AstraZeneca Pharms. LP v. Cipla Ltd., 24-8167 (D.N.J.) | 31-Jul-24 | Hon. Robert Kirsch | Lynparza® (olaparib tablets) | 12,048,695 |
| Astellas Pharma Inc. v. Qilu Pharm. (Hainan) Co., Ltd., 24-8217 (D.N.J.) | Aug. 1, 2024 | Hon. Michael A. Shipp | Xtandi® (enzalutamide tablets) | 7,709,517 11,839,689 |
| Viiv Healthcare Co. v. Hetero USA Inc., 24-0907 (D. Del.) | Aug. 2, 2024 | Hon. Mitchell S. Goldberg | Dovato® (dolutegravir / lamivudine tablets) | 9,242,986 11,234,985 |
| Astellas Pharma Inc. v. Qilu Pharm. (Hainan) Co., Ltd., 24-3747 (E.D. Pa.) | Aug. 1, 2024 | Hon. Wendy Beetlestone | Xtandi® (enzalutamide tablets) | 7,709,517 11,839,689 |
| AstraZeneca AB v. Sciegen Pharms., Inc., 24-0923 (D. Del.) | Aug. 8, 2024 | Hon. Richard G. Andrews | Farxiga® (dapagliflozin tablets) | 8,685,934 7,851,502 8,221,786 8,361,972 8,716,251 7,919,598 8,501,698 |
| AbbVie Inc. v. Hetero USA, Inc., 24-0924 (D. Del.) | Aug. 8, 2024 | Hon. Maryellen Noreika | Rinvoq® (upadacitinib tablets) | RE47,221 8,962,629 11,976,077 11,993,605 11,993,606 |
| Axsome Malta Ltd. v. Alkem Labs. Ltd., 24-8365 (D.N.J.) | Aug. 8, 2024 | Hon. Madeline Cox Arleo | Sunosi® (solriamfetol tablets) | 11,969,404 11,986,454 11,986,455 11,998,639 12,005,036 |
| Pfizer Inc. v. SpecGx LLC, 24-0927 (D. Del.) | Aug. 9, 2024 | Hon. Colm F. Connolly | Xeljanz® (tofacitinib tablets) | RE41,783 |
| Astellas Pharma Inc. v. Lupin Ltd., 24-0939 (D. Del.) | Aug. 13, 2024 | Hon. Joseph F. Bataillon | Myrbetriq® (mirabegron extended-release tablets) | 12,059,409 |
| Astellas Pharma Inc. v. Zydus Pharms. (USA) Inc., 24-0940 (D. Del.) | Aug. 13, 2024 | Hon. Joseph F. Bataillon | Myrbetriq® (mirabegron extended-release tablets) | 12,059,409 |
| Harmony Biosciences, LLC v. AET Pharma US, Inc., 24-0941 (D. Del.) | Aug. 13, 2024 | Hon. Jennifer L. Hall | Wakix® (pitolisant HCl tablets) | 8,486,947 8,207,197 |
| American Regent, Inc. v. Cipla USA, Inc., 24-8435 (D.N.J.) | Aug. 13, 2024 | Hon. Brian R. Martinotti | Tralement® (trace elements injection 4*, USP) | 11,786,548 11,975,022 11,998,565 |
| Janssen Products, L.P. v. Ever Valinject GmbH, 24-7319 (N.D. Ill.) | Aug. 15, 2024 | Hon. Sunil R. Harjani | Yondelis® (trabectedin injection) | 8,895,557 7,420,051 |
| Pfizer Inc. v. Ajanta Pharma Ltd., 24-0953 (D. Del.) | Aug. 16, 2024 | Hon. Colm F. Connolly | Xeljanz® XR (tofacitinib citrate extended-release tablets) | RE41,783 |
| Theravance Biopharma R&D IP, LLC v. Eugia Pharma Specialties Ltd., 24-8558 (D.N.J.) | Aug. 19, 2024 | Hon. Karen M. Williams | Yupelri® (revefenacin inhalation solution) | 12,048,692 |
| Axsome Malta Ltd. v. Aurobindo Pharma USA, Inc., 24-8624 (D.N.J.) | Aug. 21, 2024 | Hon. Madeline Cox Arleo | Sunosi® (solriamfetol tablets) | 11,986,454 11,986,455 11,998,639 12,005,036 |
| Ipsen Biopharms., Inc. v. Conjupro Biotherapeutics, Inc., 24-8723 (D.N.J.) | Aug. 23, 2024 | Hon. Renee Marie Bumb | Onivyde® (irinotecan liposome injection) | 12,059,497 |
| Jazz Pharms. Ireland Ltd. v. Teva Pharms., Inc., 24-8785 (D.N.J.) | Aug. 27, 2024 | Hon. Stanley R. Chesler | Xywav® (calcium, magnesium, potassium, and sodium oxybates oral solution) | 11,986,446 |
| Jazz Pharms. Ireland Ltd. v. Lupin Ltd., 24-8786 (D.N.J.) | Aug. 27, 2024 | Hon. Stanley R. Chesler | Xywav® (calcium, magnesium, potassium, and sodium oxybates oral solution) | 11,986,446 |
| Azurity Pharms., Inc. v. Annora Pharma Private Ltd., 24-8809 (D.N.J.) | Aug. 28, 2024 | Susan D. Wigenton | Firvanq® (vancomycin HCl oral solution) | 10,493,028 10,688,046 10,959,946 10,959,947 10,959,948 10,959,949 11,638,692 |
| Takeda Pharms. U.S.A., Inc. v. Colomba Therapeutics, Inc., 24-0988 (D. Del.) | Aug. 29, 2024 | Hon. Richard G. Andrews | Myinfla® (colchicine tablets) Colcrys® (colchicine tablets) | 7,964,648 |
| Intra-Cellular Therapies, Inc. v. Alkem Labs. Ltd., 24-08845 (D.N.J.) | Aug. 29, 2024 | Hon. Michael A. Shipp | Caplyta® (lumateperone capsules) | 11,980,617 12,070,459 |
| Intra-Cellular Therapies, Inc. v. Aurobindo Pharma Ltd., 24-08848 (D.N.J.) | Aug. 29, 2024 | Hon. Michael A. Shipp | Caplyta® (lumateperone capsules) | 11,980,617 12,070,459 |
| Intra-Cellular Therapies, Inc. v. Dr. Reddy’s Labs. Inc., 24-08850 (D.N.J.) | Aug. 29, 2024 | Hon. Michael A. Shipp | Caplyta® (lumateperone capsules) | 11,980,617 12,070,459 |
| Intra-Cellular Therapies, Inc. v. Hetero USA, Inc., 24-08852 (D.N.J.) | Aug. 29, 2024 | Hon. Michael A. Shipp | Caplyta® (lumateperone capsules) | 11,980,617 12,070,459 |
| Intra-Cellular Therapies, Inc. v. MSN Labs. Private Ltd., 24-08854 (D.N.J.) | Aug. 29, 2024 | Hon. Michael A. Shipp | Caplyta® (lumateperone capsules) | 11,980,617 12,070,459 |
| Intra-Cellular Therapies, Inc. v. Sandoz Inc., 24-08855 (D.N.J.) | Aug. 29, 2024 | Hon. Michael A. Shipp | Caplyta® (lumateperone capsules) | 11,980,617 12,070,459 |
| Intra-Cellular Therapies, Inc. v. Zydus Pharms. (USA) Inc., 24-08856 (D.N.J.) | Aug. 29, 2024 | Hon. Michael A. Shipp | Caplyta® (lumateperone capsules) | 11,980,617 12,070,459 |
| Boehringer Ingelheim Pharms. Inc. v. Mylan Pharms. Inc., 24-0082 (N.D.W.V.) | Aug. 30, 2024 | Hon. Thomas S. Kleeh | Tradjenta® (linagliptin tablets) Jentadueto® (linagliptin / metformin tablets) | 11,911,388 |
| Otsuka Pharm. Co., Ltd. v. Apotex Inc., 24-1004 (D. Del.) | Aug. 30, 2024 | Hon. Jennifer L. Hall | Abilify Maintena® (aripiprazole extended-release injectable suspension) | 10,525,057 10,980,803 11,154,553 11,344,547 11,400,087 11,648,347 |
| Novo Nordisk Inc. v. Mylan Pharms. Inc., 24-1013 (D. Del.) | Sept. 5, 2024 | Hon. Colm F. Connolly | Wegovy® (semaglutide injection) | 12,029,779 |
| Novo Nordisk Inc. v. Sun Pharm. Indus. Ltd., 24-1014 (D. Del.) | Sept. 5, 2024 | Hon. Colm F. Connolly | Wegovy® (semaglutide injection) | 12,029,779 |
| American Regent, Inc. v. Eugia Pharma Specialities Ltd., 24-8956 (D.N.J.) | Sept. 5, 2024 | Hon. Brian R. Martinotti | Selenious Acid | 11,998,565 |
| Rayner Surgical Inc. v. Somerset Therapeutics, LLC, 24-9017 (D.N.J.) | Sept. 6, 2024 | Hon. Evelyn Padin | Omidria® (phenylephrine / ketorolac injection) | 9,066,856 9,486,406 9,855,246 |
| Ingenus Pharms., LLC v. Hetero USA, Inc., 24-1025 (D. Del.) | Sept. 11, 2024 | Hon. Jennifer L. Hall | cyclophosphamide injection | 10,993,952 |
| Jazz Pharms. Ireland Ltd. v. Sandoz, Inc., 24-9110 (D.N.J.) | Sept. 11, 2024 | Hon. Robert Kirsch | Zepzelca® (lurbinectedin injection) | 7,763,615 |
| Jazz Pharms. Ireland Ltd. v. RK Pharma, Inc., 24-1028 (D. Del.) | Sept. 12, 2024 | Hon. Gregory B. Williams | Zepzelca® (lurbinectedin injection) | 7,763,615 |
| Aragon Pharms., Inc. v. Zydus Worldwide DMCC, 24-9134 (D.N.J.) | Sept. 12, 2024 | Hon. Stanley R. Chesler | Erleada® (apalutamide tablets) | 11,963,952 |
| Boehringer Ingelheim Pharms., Inc. v. Anobri Pharms. US, LLC, 24-9135 (D.N.J.) | Sept. 12, 2024 | Hon. Claire C. Cecchi | Stiolto® Respimat® (tiotropium bromide / olodaterol HCl inhalation spray) | 7,396,341 9,027,967 7,837,235 8,733,341 |
| Jazz Pharms. Ireland Ltd. v. InvaGen Pharms., Inc., 24-6416 (E.D.N.Y.) | Sept. 12, 2024 | Hon. Joan M. Azrack | Zepzelca® (lurbinectedin injection) | 7,763,615 |
| Novartis Pharms. Corp. v. Natco Pharma Ltd., 24-1033 (D. Del.) | Sept. 13, 2024 | Hon. Jennifer L. Hall | Kisqali® (ribociclib tablets) | 9,193,732 9,868,739 |
| Mallinckrodt Pharms. Ireland Ltd. v. Baxter Healthcare Corp., 24-1034 (D. Del.) | Sept. 13, 2024 | Hon. Gregory B. Williams | Ofirmev® (acetaminophen injection) | 9,399,012 9,610,265 9,987,238 10,383,834 |
| Axsome Malta Ltd. v. Alkem Labs. Ltd., 24-9209 (D.N.J.) | Sept. 16, 2024 | Hon. Madeline Cox Arleo | Sunosi® (solriamfetol tablets) | 11,969,404 11,986,454 11,986,455 11,998,639 12,005,036 12,036,194 12,064,411 |
| Novartis Pharms. Corp. v. Lupin Inc., 24-1045 (D. Del.) | Sept. 18, 2024 | Hon. Richard G. Andrews | Entresto® (sacubitril / valsartan tablets) | 8,101,659 11,096,918 |
| Supernus Pharms., Inc. v. Micro Labs Ltd., 24-9338 (D.N.J.) | Sept. 20, 2024 | Hon. Zahid N. Quraishi | Trokendi XR® (topiramate extended-release capsules) | 8,298,576 8,298,580 8,663,683 8,877,248 8,889,191 8,992,989 9,549,940 9,555,004 9,622,983 10,314,790 |
| Supernus Pharms., Inc. v. Aurobindo Pharma Ltd., 24-9380 (D.N.J.) | Sept. 23, 2024 | Hon. Karen M. Williams | Oxtellar XR® (oxcarbazepine extended-release tablets) | 7,722,898 7,910,131 8,617,600 8,821,930 9,119,791 9,351,975 9,370,525 9,855,278 10,220,042 11,166,960 11,896,599 |
| Endo Operations, Ltd. v. Fresenius Kabi USA, LLC, 24-1065 (D. Del.) | Sept. 24, 2024 | Hon. Maryellen Noreika | Adrenalin® (epinephrine injection) | 9,119,876 9,295,657 10,130,592 |
| Astellas Pharma Inc. v. Lupin Ltd., 24-1068 (D. Del.) | Sept. 24, 2024 | Hon. Joseph F. Bataillon | Myrbetriq® (mirabegron extended-release tablets) | 12,097,189 |
| Astellas Pharma Inc. v. Zydus Pharms. (USA) Inc., 24-1069 (D. Del.) | Sept. 24, 2024 | Hon. Joseph F. Bataillon | Myrbetriq® (mirabegron extended-release tablets) | 12,097,189 |
| Astellas Pharma Inc. v. Haimen Pharma Inc., 24-9403 (D.N.J.) | Sept. 24, 2024 | Hon. Michael A. Shipp | Xtandi® (enzalutamide tablets) | 7,709,517 11,839,689 |
| Hikma Pharms. USA Inc. v. SK Biopharmaceuticals Co., Ltd., IPR2024-01418 (PTAB) | Sept. 24, 2024 | N/A | Sunosi® (solriamfetol HCl tablets) | 11,560,354 |
| Esperion Therapeutics, Inc. v. Aurobindo Pharma Ltd., 24-9457 (D.N.J.) | Sept. 25, 2024 | Hon. Julien Xavier Neals | Nexlizet® (bempedoic acid / ezetimibe tablets)) | 11,760,714 11,613,511 10,912,751 11,744,816 11,926,584 |
| Ultragenyx Pharm. Inc. v. Navinta LLC, 24-9483 (D.N.J.) | Sept. 26, 2024 | Hon. Esther Salas | Dojolvi® (triheptanoin oral liquid) | 8,697,748 |
| Astellas Pharma Inc. v. Ascent Pharms., Inc., 24-1084 (D. Del.) | Sept. 27, 2024 | Hon. Joseph F. Bataillon | Myrbetriq® (mirabegron extended-release tablets) | 12,059,409 11,707,451 12,097,189 |
| Salix Pharms., Inc. v. Zydus Pharms. (USA) Inc., 24-9512 (D.N.J.) | Sept. 27, 2024 | Hon. Edward S. Kiel | Xifaxan® (rifaximin tablets) | 11,779,571 11,564,912 8,193,196 8,518,949 8,741,904 9,271,968 10,703,763 |
| Bristol-Myers Squibb Co. v. Umedica Labs. Pvt. Ltd., 24-1089 (D. Del.) | Sept. 30, 2024 | Hon. Gregory B. Williams | Eliquis® (apixaban tablets) | 9,326,945 |
| Boehringer Ingelheim Pharms. Inc. v. Granules India Ltd., 24-1091 (D. Del.) | Sept. 30, 2024 | Hon. Colm F. Connolly | Jentadueto® (linagliptin / metformin HCl tablets) | 9,155,705 9,415,016 10,022,379 10,973,827 11,911,388 |
| Axsome Therapeutics, Inc. v. Teva Pharms., Inc., 24-9535 (D.N.J.) | Sept. 30, 2024 | Hon. Madeline Cox Arleo | Auvelity® (dextromethorphan hydrobromide / bupropion HCl extended-release tablets) | 11,986,444 12,036,191 12,042,473 |
